Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Millennium Pharmaceuticals Inc. v. Apotex Corp. (D. Del. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Millennium Pharmaceuticals Inc. v. Apotex Corp. (D. Del. 2013)

Docket   Start Trial Date Filed 2013-11-08
Court District Court, D. Delaware Date Terminated 2015-10-01
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Patents 6,713,446; 6,958,319
Attorneys Alexandra J. Olson; Andrew M. Alul; Andrew Russell; Jack B. Blumenfeld; John W. Shaw; Karen Elizabeth Keller; Mark D. Schuman; Maryellen Noreika; Paul J. Molino; Richard D. Kirk; Samuel T. Lockner; Stephanie E. O'Byrne; Stephen B. Brauerman; Thomas H. Ehrich; Todd S. Werner; Vanessa Ribeiro Tiradentes; William A. Rakoczy; Yixin H. Tang
Firms Bayard, P.A.; Gould & Ratner LLP; Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Apotex Corp.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Millennium Pharmaceuticals Inc. v. Apotex Corp. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-11-08 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2;. …2013 1 October 2015 1:13-cv-01874 830 Patent None District Court, D. Delaware External link to document
2015-10-01 57 to the expiration of U.S. Patent Nos. 6,713,446 ("the '446 patent") and 6,958,319 ("…validity of claims 20, 31, 49, and 53 of U.S. Patent No. 6, 713,446 in this action based on the Court's … to the expiration of the '446 patent and the '319 patent; Case 1:13-cv-01874-GMS Document 57…the '446 patent and claims 25-26, 40, 54, 57, 62, 66, and 70 ofthe '319 patent; 5. …quot;the '319 patent"); 3. Defendant Apotex Inc. filed Abbreviated New Drug Application External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.